Merck Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

07.08.2025 - 17:58:51

Merck, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance Biotech Grant. The Boston-based biotech startup develops AI-designed gene editing therapies for Parkinson’s disease.

to register online, change your selection or discontinue this service.